{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:04:53Z","timestamp":1792800293944,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The French Society of Cancer in Children and Adolescents"},{"name":"The Gustave Roussy Foundation","id":[{"id":"https:\/\/ror.org\/05rfnt234","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"crossref","award":["INCA RISP-SHS 2022"],"award-info":[{"award-number":["INCA RISP-SHS 2022"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-024-03797-8","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T03:02:42Z","timestamp":1725937362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neurological hospitalisations in childhood cancer survivors treated before 2001: findings from the French Childhood Cancer Survivor Study cohort"],"prefix":"10.1186","volume":"24","author":[{"given":"David","family":"Rajaonera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bejarano-Quisoboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigue S.","family":"Allodji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Pelletier-Fleury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neige","family":"Journy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Boussac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Doz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giao","family":"Vu-Bezin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Zidane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Haddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Bolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiraz","family":"El-Fayech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahima","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Schleiermacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice","family":"Fresneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"de Vathaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"3797_CR1","doi-asserted-by":"publisher","unstructured":"Armstrong GT, Yasui Y, Robison LL. Reduction in late mortality after Childhood Cancer. N Engl J Med. 2016;375(3). https:\/\/doi.org\/10.1056\/NEJMc1604184.","DOI":"10.1056\/NEJMc1604184"},{"key":"3797_CR2","doi-asserted-by":"publisher","unstructured":"Tsimberidou AM, et al. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat Rev. 2020;86. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102019.","DOI":"10.1016\/j.ctrv.2020.102019"},{"key":"3797_CR3","doi-asserted-by":"publisher","unstructured":"Botta L, et al. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study. Lancet Oncol. 2022;23(12). https:\/\/doi.org\/10.1016\/S1470-2045(22)00637-4.","DOI":"10.1016\/S1470-2045(22)00637-4"},{"key":"3797_CR4","doi-asserted-by":"publisher","unstructured":"Hudson MM, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309(22). https:\/\/doi.org\/10.1001\/jama.2013.6296.","DOI":"10.1001\/jama.2013.6296"},{"key":"3797_CR5","doi-asserted-by":"publisher","unstructured":"Oeffinger KC, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15). https:\/\/doi.org\/10.1056\/NEJMsa060185.","DOI":"10.1056\/NEJMsa060185"},{"key":"3797_CR6","doi-asserted-by":"publisher","unstructured":"Diller L, et al. Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol. 2009;27(14). https:\/\/doi.org\/10.1200\/jco.2008.21.1953.","DOI":"10.1200\/jco.2008.21.1953"},{"key":"3797_CR7","doi-asserted-by":"publisher","unstructured":"Mohrmann C, et al. Neurocognitive outcomes and school performance in solid tumor cancer survivors lacking therapy to the central nervous system. J Pers Med. 2015;5(2). https:\/\/doi.org\/10.3390\/jpm5020083.","DOI":"10.3390\/jpm5020083"},{"key":"3797_CR8","doi-asserted-by":"publisher","unstructured":"Bhakta N, et al. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). Lancet. 2017;390(10112). https:\/\/doi.org\/10.1016\/s0140-6736(17)31610-0.","DOI":"10.1016\/s0140-6736(17)31610-0"},{"key":"3797_CR9","doi-asserted-by":"publisher","unstructured":"Cheung YT, et al. Chronic health conditions and neurocognitive function in aging survivors of Childhood Cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2018;110(4). https:\/\/doi.org\/10.1093\/jnci\/djx224.","DOI":"10.1093\/jnci\/djx224"},{"key":"3797_CR10","doi-asserted-by":"publisher","unstructured":"Champaloux SW, Young DR. Childhood chronic health conditions and educational attainment: a social ecological approach. J Adolesc Health. 2015;56(1). https:\/\/doi.org\/10.1016\/j.jadohealth.2014.07.016.","DOI":"10.1016\/j.jadohealth.2014.07.016"},{"key":"3797_CR11","doi-asserted-by":"publisher","unstructured":"Vassilaki M, et al. Multimorbidity and risk of mild cognitive impairment. J Am Geriatr Soc. 2015;63(9). https:\/\/doi.org\/10.1111\/jgs.13612.","DOI":"10.1111\/jgs.13612"},{"key":"3797_CR12","doi-asserted-by":"publisher","unstructured":"Clanton NR, et al. Fatigue, vitality, sleep, and neurocognitive functioning in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2011;117(11). https:\/\/doi.org\/10.1002\/cncr.25797.","DOI":"10.1002\/cncr.25797"},{"key":"3797_CR13","doi-asserted-by":"publisher","unstructured":"Krull KR, et al. Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study. J Clin Oncol. 2013;31(35). https:\/\/doi.org\/10.1200\/jco.2012.48.2315.","DOI":"10.1200\/jco.2012.48.2315"},{"key":"3797_CR14","doi-asserted-by":"publisher","unstructured":"Grill J, et al. Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage. J Neurosurg. 2004;101(2 Suppl). https:\/\/doi.org\/10.3171\/ped.2004.101.2.0152.","DOI":"10.3171\/ped.2004.101.2.0152"},{"key":"3797_CR15","doi-asserted-by":"publisher","unstructured":"Blauwblomme T, et al. Forniceal glioma in children. Clinical article. J Neurosurg Pediatr. 2009;4(3). https:\/\/doi.org\/10.3171\/2009.4.Peds08472.","DOI":"10.3171\/2009.4.Peds08472"},{"key":"3797_CR16","doi-asserted-by":"publisher","unstructured":"Krull KR, et al. Neurocognitive function and CNS integrity in adult survivors of childhood hodgkin lymphoma. J Clin Oncol. 2012;30(29). https:\/\/doi.org\/10.1200\/jco.2012.42.6841.","DOI":"10.1200\/jco.2012.42.6841"},{"key":"3797_CR17","doi-asserted-by":"publisher","unstructured":"Bejarano-Quisoboni D, et al. Long-term hospitalisations in survivors of paediatric solid tumours in France. Sci Rep. 2022;12(1). https:\/\/doi.org\/10.1038\/s41598-022-22689-w.","DOI":"10.1038\/s41598-022-22689-w"},{"key":"3797_CR18","doi-asserted-by":"publisher","unstructured":"Kenborg L, et al. Hospital admission for neurologic disorders among 5-year survivors of noncentral nervous system tumors in childhood: a cohort study within the adult life after Childhood Cancer in Scandinavia study. Int J Cancer. 2020;146(3). https:\/\/doi.org\/10.1002\/ijc.32341.","DOI":"10.1002\/ijc.32341"},{"key":"3797_CR19","doi-asserted-by":"publisher","unstructured":"Kenborg L, et al. Neurologic disorders in 4858 survivors of central nervous system tumors in childhood-an adult life after Childhood Cancer in Scandinavia (ALiCCS) study. Neuro Oncol. 2019;21(1). https:\/\/doi.org\/10.1093\/neuonc\/noy094.","DOI":"10.1093\/neuonc\/noy094"},{"key":"3797_CR20","doi-asserted-by":"publisher","unstructured":"Journy NMY, et al. Risk factors of subsequent Central Nervous System tumors after Childhood and adolescent cancers: findings from the French Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2021;30(1). https:\/\/doi.org\/10.1158\/1055-9965.epi-20-0735.","DOI":"10.1158\/1055-9965.epi-20-0735"},{"key":"3797_CR21","unstructured":"de Vathaire F et al. Solid malignant neoplasms after childhood irradiation: decrease of the relative risk with time after irradiation. C R Acad Sci III, 1995. 318(4)."},{"key":"3797_CR22","doi-asserted-by":"publisher","unstructured":"Haddy N, et al. Cardiac diseases following Childhood Cancer Treatment: Cohort Study. Circulation. 2016;133(1). https:\/\/doi.org\/10.1161\/circulationaha.115.016686.","DOI":"10.1161\/circulationaha.115.016686"},{"key":"3797_CR23","doi-asserted-by":"publisher","unstructured":"Bejarano-Quisoboni D, et al. Health care expenditures among long-term survivors of pediatric solid tumors: results from the French Childhood Cancer Survivor Study (FCCSS) and the French network of cancer registries (FRANCIM). PLoS ONE. 2022;17(5). https:\/\/doi.org\/10.1371\/journal.pone.0267317.","DOI":"10.1371\/journal.pone.0267317"},{"key":"3797_CR24","doi-asserted-by":"publisher","unstructured":"Bezin J, et al. The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2017;26(8). https:\/\/doi.org\/10.1002\/pds.4233.","DOI":"10.1002\/pds.4233"},{"key":"3797_CR25","doi-asserted-by":"publisher","unstructured":"Tuppin P, et al. Value of a national administrative database to guide public decisions: From the systeme national d\u2019information interregimes de l\u2019Assurance Maladie (SNIIRAM) to the systeme national des donnees de sante (SNDS) in France. Rev Epidemiol Sante Publique. 2017;65(Suppl 4). https:\/\/doi.org\/10.1016\/j.respe.2017.05.004.","DOI":"10.1016\/j.respe.2017.05.004"},{"key":"3797_CR26","doi-asserted-by":"crossref","unstructured":"Fieller EC. Some problems in interval estimation. J Royal Stat Soc Ser B (Methodological), 1954. 16(2).","DOI":"10.1111\/j.2517-6161.1954.tb00159.x"},{"key":"3797_CR27","doi-asserted-by":"publisher","unstructured":"Streefkerk N, et al. A detailed insight in the high risks of hospitalizations in long-term childhood cancer survivors-A Dutch LATER linkage study. PLoS ONE. 2020;15(5). https:\/\/doi.org\/10.1371\/journal.pone.0232708.","DOI":"10.1371\/journal.pone.0232708"},{"key":"3797_CR28","doi-asserted-by":"publisher","unstructured":"de Fine Licht S, et al. Long-term inpatient disease burden in the adult life after Childhood Cancer in Scandinavia (ALiCCS) study: a cohort study of 21,297 childhood cancer survivors. PLoS Med. 2017;14(5). https:\/\/doi.org\/10.1371\/journal.pmed.1002296.","DOI":"10.1371\/journal.pmed.1002296"},{"key":"3797_CR29","doi-asserted-by":"publisher","unstructured":"Kirchhoff AC, et al. Risk of hospitalization for survivors of childhood and adolescent cancer. Cancer Epidemiol Biomarkers Prev. 2014;23(7). https:\/\/doi.org\/10.1158\/1055-9965.epi-13-1090.","DOI":"10.1158\/1055-9965.epi-13-1090"},{"key":"3797_CR30","doi-asserted-by":"publisher","unstructured":"Kurt BA, et al. Hospitalization rates among survivors of childhood cancer in the Childhood Cancer Survivor Study cohort. Pediatr Blood Cancer. 2012;59(1). https:\/\/doi.org\/10.1002\/pbc.24017.","DOI":"10.1002\/pbc.24017"},{"key":"3797_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6641","author":"I Agapito","year":"2023","unstructured":"Agapito I, et al. Neuropsychiatric complications and associated management in adolescent and young adult cancer survivors: an all of us study. Cancer Med. 2023. https:\/\/doi.org\/10.1002\/cam4.6641.","journal-title":"Cancer Med"},{"key":"3797_CR32","doi-asserted-by":"publisher","unstructured":"Norsker FN, et al. Neurologic disorders in long-term survivors of neuroblastoma - a population-based cohort study within the adult life after Childhood Cancer in Scandinavia (ALiCCS) research program. Acta Oncol. 2020;59(2). https:\/\/doi.org\/10.1080\/0284186x.2019.1672892.","DOI":"10.1080\/0284186x.2019.1672892"},{"key":"3797_CR33","doi-asserted-by":"publisher","unstructured":"Wells EM, et al. Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report. Neuro Oncol. 2018;20(1). https:\/\/doi.org\/10.1093\/neuonc\/nox148.","DOI":"10.1093\/neuonc\/nox148"},{"key":"3797_CR34","doi-asserted-by":"publisher","unstructured":"Krull KR, et al. Neurocognitive outcomes and interventions in long-term survivors of Childhood Cancer. J Clin Oncol. 2018;36(21). https:\/\/doi.org\/10.1200\/jco.2017.76.4696.","DOI":"10.1200\/jco.2017.76.4696"},{"key":"3797_CR35","doi-asserted-by":"publisher","unstructured":"Sun LR, Cooper S. Neurological complications of the treatment of Pediatric Neoplastic disorders. Pediatr Neurol. 2018;85. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2018.05.011.","DOI":"10.1016\/j.pediatrneurol.2018.05.011"},{"key":"3797_CR36","doi-asserted-by":"publisher","first-page":"8417","DOI":"10.1016\/s0140-6736(84)91621-0","volume":"2","author":"JJ Ochs","year":"1984","unstructured":"Ochs JJ, et al. Seizures in childhood lymphoblastic leukaemia patients. Lancet. 1984;2:8417\u20138. https:\/\/doi.org\/10.1016\/s0140-6736(84)91621-0.","journal-title":"Lancet"},{"key":"3797_CR37","doi-asserted-by":"publisher","unstructured":"Green DM, et al. Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors. Pediatr Blood Cancer. 2013;60(7). https:\/\/doi.org\/10.1002\/pbc.24487.","DOI":"10.1002\/pbc.24487"},{"key":"3797_CR38","unstructured":"https:\/\/www.atih.sante.fr\/sites\/default\/files\/public\/content\/3675\/synthese_aah_2018_v2.pdf, Synth\u00e8se Analyse de l\u2019activit\u00e9 hospitali\u00e8re 2018 2018."},{"key":"3797_CR39","doi-asserted-by":"publisher","unstructured":"Tuppin P, et al. French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publique. 2010;58(4). https:\/\/doi.org\/10.1016\/j.respe.2010.04.005.","DOI":"10.1016\/j.respe.2010.04.005"},{"key":"3797_CR40","doi-asserted-by":"publisher","unstructured":"Haden MA, Keats TE. Congenital intraspinal neuroblastoma with intraspinal calcification in the neonatal period: report of a case with a 32-year follow-up. Pediatr Radiol. 1983;13(6). https:\/\/doi.org\/10.1007\/BF01625961.","DOI":"10.1007\/BF01625961"},{"key":"3797_CR41","unstructured":"Po\u0142czy\u0144ska K et al. [Neurologic symptoms in the course of neuroblastoma in children. Own observations]. Med Wieku Rozwoj, 2005. 9(3 Pt 2)."},{"key":"3797_CR42","doi-asserted-by":"publisher","unstructured":"Dyken P, Kol\u00e1r O. Dancing eyes, dancing feet: infantile polymyoclonia. Brain. 1968;91(2). https:\/\/doi.org\/10.1093\/brain\/91.2.305.","DOI":"10.1093\/brain\/91.2.305"},{"key":"3797_CR43","doi-asserted-by":"publisher","unstructured":"Du H, Cai W. Opsoclonus-Myoclonus syndrome associated with neuroblastoma: insights into antitumor immunity. Pediatr Blood Cancer. 2022;69(11). https:\/\/doi.org\/10.1002\/pbc.29949.","DOI":"10.1002\/pbc.29949"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03797-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03797-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03797-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T03:05:54Z","timestamp":1725937554000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03797-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3797"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03797-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"5 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with French regulations, the study protocol was approved by a regional ethics committee of the INSERM and by the French Data Protection Authority (<i>Commission Nationale de l\u2019Informatique et des Libert\u00e9s \u2013 CNIL<\/i> Authorization n\u00b0902287<i>).<\/i> Individual patient informed consent was not required for this study because we obtained a specific act in law from the French \u201cConseil d\u2019Etat\u201d, the highest court in France (Order 2014-96 of 2014 February 3), that approved access to the SNDS for all survivors included in the FCCSS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"335"}}